Clover to Participate at Upcoming Investor Conferences
CHENGDU, China, March 03, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a…
CHENGDU, China, March 03, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a…
The report gathers key quantifiable business impacts experienced by customers OTTAWA, March 03, 2022 (GLOBE…
Zug, Switzerland–(Newsfile Corp. – March 3, 2022) – Polkadot is excited to announce plans to…
Builds momentum towards fast-growing opportunity in net-zero and carbon accounting with products powered by sensor…
NEW YORK–(BUSINESS WIRE)–Ares Capital Corporation (“Ares Capital”) (NASDAQ:ARCC) announced today that Kipp deVeer, Ares Capital’s…
Longstanding client renews VSM contract for ongoing management of business associate risk AUSTIN, Texas–(BUSINESS WIRE)–$CTEK…
Company announcement – No. 6 / 2022 Zealand Pharma Hosts Conference Call on March 10 at…
Receiving advisory services and up to C$404,000 in funding from the National Research Council of…
Singapore, Singapore–(Newsfile Corp. – March 3, 2022) – MetaGear, a Simulation Combat Blockchain-based game, announced…
The leading fleet management company has added Icon Ventures partner Dana Evan and Lime president…
New Funding to Accelerate Platform Innovation and Fuel Rapid Market Expansion with Public Transport Agencies…
VMware announces research grants for 6G-life and CeTI at TU Dresden and Telecommunication Networks Group…
NEW YORK–(BUSINESS WIRE)–Aqara, a leading provider of smart home products, announced the wide availability of…
VYVGART® (efgartigimod alfa-fcab) approved in the U.S. and Japan as the first-and-only neonatal Fc receptor…
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – March 3, 2022Idorsia Ltd…
Featuring approximately 1.2x processing speed and 20% less power consumption, Samsung’s LPDDR5X DRAM will boost…
NEWTON, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
BOCA RATON, Fla., March 02, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ: FWBI)…
SALT LAKE CITY, March 02, 2022 (GLOBE NEWSWIRE) — Paul J. Diaz, president and CEO…
Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in…